MedTrace Logo

Depression Amongst HIV Positive Patients in Lilongwe

NCT02646605 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 206

Last updated 2016-01-05

No results posted yet for this study

Summary

Quantitative, validated tools of depression screening will be used to collect data to determine the prevalence of depression and its association with antiretroviral (ARV) adherence amongst HIV positive patients attending ART clinic at Lighthouse Lilongwe, Malawi.

Conditions

Interventions

OTHER

depression screening

Patient Health Questionnaire

Sponsors & Collaborators

  • Fogarty AIDS international training research program

    collaborator UNKNOWN

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Mina Hosseinipour, MD, MPH · University of North Carolina, Chapel Hill

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2013-09-30
Completion
2013-09-30

Countries

  • Malawi

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02646605 on ClinicalTrials.gov